1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Activated PI3K-delta Syndrome: new trials by email Literature Review of Activated PI3K-delta Syndrome trials Research Report on Activated PI3K-delta Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome Rapamycin - Activated PI3K-delta Syndrome, Immunodeficiency Primary | Phase 1 / Phase 2 | Completed | Children's Hospital of Fudan University | 30 | 2017-12-01 | 2024-07-09 |
Primary Immunodeficiency Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Sirolimus (1)
Children's Hospital of Fudan University (1)
China (1)